SMTL ID : 4g2l.1 (2 other biounits)

Human PDE9 in complex with selective compound

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.79, H.115, D.116, D.225 Ligands: MG.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.79, A:H.115, A:D.116, A:D.225

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: H.115, D.116, H.148 Ligands: ZN.1 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:D.116

1 x 0WL: 1-cyclopentyl-6-{(1R)-1-[3-(pyrimidin-2-yl)azetidin-1-yl]ethyl}-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)

0WL.3: 9 residues within 4Å: Chain A: M.188, I.226, E.229, L.243, Y.247, F.264, A.275, Q.276, F.279 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.226, A:L.243, A:Y.247, A:F.264, A:A.275 Hydrogen bonds: A:Q.276, A:Q.276 pi-Stacking: A:F.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Claffey, M.M. et al., Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors. J.Med.Chem. (2012)

Release Date

2013-05-29

Peptides

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A

Related Entries With Identical Sequence